OIS at AAO 2015

Aerie Pharmaceuticals

Nov 12, 2015 4:00pm ‐ Nov 12, 2015 4:10pm


We are a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Glaucoma is one of the largest segments in the global ophthalmic market.


You must be logged in and own this session in order to post comments.